The global contraceptive devices market is expected to grow at a CAGR of 7.5% in the first half of the forecast period. In 2016, the market was estimated at $12.1bn and dominated by the condoms submarket followed by the IUD submarket.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 186-page report you will receive 67 tables and 84 figures– all unavailable elsewhere.
The 186-page report provides clear detailed insight into the global contraceptive devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Contraceptive Devices Market Forecast to 2027
• This report also breaks down the revenue forecast for the global contraceptive devices market by type:
– Condoms: Male and Female
– Diaphragms
– Sponges
– Vaginal Rigs
– Subdermal/Contraceptive Implants
– IUDs: Copper IUD and Hormonal IUD
• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America: US & Canada
– Europe: the UK, Germany, France, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
– Rest of the World (RoW): Latin America, Middle East & Africa
• This report discusses the SWOT Analysis and PEST Analysis of the global contraceptive devices market.
• Our study discusses the selected leading companies that are the major players in the global contraceptive devices market:
– Bayer AG
– Reckitt Benckiser Group plc
– Merck Sharp & Dohme Corp.
– Church & Dwight Co., Inc.
– Teva Pharmaceutical Industries, Ltd.
– Allergan plc
– Ansell Limited (Now Humanwell)
– The Female Health Company (a division of VERU Inc.)
– Karex Industries
– Mayer Laboratories
– Kessel Medintim GmbH
– Okamato Industries, Inc.
– Agile Therapeutics, Inc.
– Eurogine S.L.
Visiongain’s study is intended for anyone requiring commercial analyses for the global contraceptive devices market. You find data, trends and predictions.
Buy our report today Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Contraceptive Devices Market Overview
1.2 Overview of Findings
1.3 Global Contraceptive Devices Market Segmentation
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report Include:
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to the Contraceptive Devices Market
2.1 Contraceptive Devices Market Definition
2.2 Evolution of Contraceptive Devices
2.2.1 Snapshot: Evolution of Contraceptive Devices
2.2.2 Currently Available Contraceptive Devices
2.2.3 Future of Contraceptive Devices
2.2.4. Contraceptive Devices in Development
3. Global Contraceptive Devices Market Forecast to 2027
3.1 Global contraceptive Devices Market Forecast to 2027
3.2 Global Contraceptive Devices Market Dynamics, 2017
4. Global Contraceptive Devices Market by Type: Market Forecast to 2027
4.1 Global Condoms Market Forecast to 2027
4.2 Global Diaphragms Market Forecast to 2027
4.3 Global Sponges Market Forecast to 2027
4.4 Global Vaginal Rings Market Forecast to 2027
4.5 Global Subdermal Implants/ Contraceptive Implant Market Forecast to 2027
4.6 Global Intrauterine Devices/ Systems (IUD’s and IUS’s) Market Forecast to 2027
5. Leading National Markets Forecast to 2027
5.1 North America Contraceptive Devices Market Forecast to 2027
5.1.1 The U.S. Contraceptive Devices Market Forecast to 2027
5.1.2 Canada Contraceptive Devices Market Forecast to 2027
5.2 Europe Contraceptive Devices Market Forecast to 2027
5.2.1 U.K. Contraceptive Devices Market Forecast to 2027
5.2.2 Germany Contraceptive Devices Market Forecast to 2027
5.2.3 France Contraceptive Devices Market Forecast to 2027
5.2.4 Italy Contraceptive Devices Market Forecast to 2027
5.2.5 Rest of Europe Contraceptive Devices Market Forecast to 2027
5.3 Asia-Pacific Contraceptive Devices Market Forecast to 2027
5.3.1 China Contraceptive Devices Market Forecast to 2027
5.3.2 Japan Contraceptive Devices Market Forecast to 2027
5.3.3 India Contraceptive Devices Market Forecast to 2027
5.3.4 Rest of Asia-Pacific Contraceptive Devices Market Forecast to 2027
5.4 Rest of the World (ROW) Contraceptive Devices Market Forecast to 2027
5.4.1 Latin America Contraceptive Devices Market Forecast to 2027
5.4.2 Middle East & Africa Contraceptive Devices Market Forecast to 2027
6. Leading Companies in the Contraceptive Devices Market
6.1 Bayer AG
6.1.1 Bayer AG: Business Overview
6.1.2 Bayer AG: Financial Overview
6.1.3 Bayer AG: Product Portfolio
6.1.4 Bayer AG - Recent Developments (2014-2017)
6.1.5 Bayer AG - SWOT Analysis
6.2 Reckitt Benckiser Group plc
6.2.1 Reckitt Benckiser Group plc: Business Overview
6.2.2 Reckitt Benckiser Group plc: Financial Overview
6.2.3 Reckitt Benckiser Group plc: Product Portfolio
6.2.4 Reckitt Benckiser Group plc: Recent Developments (2014-2017)
6.2.5 Reckitt Benckiser Group plc: SWOT Analysis
6.3 Merck Sharp & Dohme Corp.
6.3.1 Merck Sharp & Dohme Corp.: Business Overview
6.3.2 Merck Sharp & Dohme Corp.: Financial Overview
6.3.3 Merck Sharp & Dohme Corp.: Product Portfolio
6.3.3 Merck Sharp & Dohme Corp.: SWOT Analysis
6.4 Church & Dwight Co., Inc.
6.4.1 Church & Dwight Co., Inc.: Business Overview
6.4.2 Church & Dwight Co., Inc.: Financial Overview
6.4.3 Church & Dwight Co., Inc.: Product Portfolio
6.4.4 Church & Dwight Co., Inc.: Recent Developments (2014-2017)
6.5 Teva Pharmaceuticals Industries, Ltd.
6.5.1 Teva Pharmaceuticals Industries, Ltd.: Business Overview
6.5.2 Teva Pharmaceuticals Industries, Ltd.: Financial Overview
6.5.3 Teva Pharmaceuticals Industries, Ltd.: Product Portfolio
6.5.4 Teva Pharmaceuticals Industries, Ltd.: Recent Developments (2014-2017)
6.6 Allergan, PLC.
6.6.1 Allergan, PLC.: Business Overview
6.6.2 Allergan, PLC.: Financial Overview
6.6.3 Allergan, PLC.: Product Portfolio
6.6.4 Allergan, PLC.: Recent Developments (2014-2017)
6.6.5 Allergan, PLC.: SWOT Analysis
6.7 Ansell Limited (Now Humanwell)
6.7.1 Ansell Limited (Now Humanwell): Business Overview
6.7.2 Ansell Limited (Now Humanwell): Financial Overview
6.7.3 Ansell Limited (Now Humanwell): Product Portfolio
6.7.4 Ansell Limited (Now Humanwell): Recent Developments (2014-2017)
6.7.5 Ansell Limited (Now Humanwell): SWOT Analysis
6.8 The Female Health Company (A division of VERU Inc.)
6.8.1 The Female Health Company (A division of VERU Inc.): Business Overview
6.8.2 The Female Health Company (A division of VERU Inc.): Financial Overview
6.8.3 The Female Health Company (A division of VERU Inc.): Product Portfolio
6.8.4 The Female Health Company (A division of VERU Inc.): Recent Developments (2014-2017)
6.9 Karex Industries
6.9.1 Karex Industries: Business Overview
6.9.2 Karex Industries: Financial Overview
6.9.3 Karex Industries: Product Portfolio
6.9.4 Karex Industries: Recent Developments (2014-2017)
6.9.5 Karex Industries: SWOT Analysis
6.10 Mayer Laboratories
6.10.1 Mayer Laboratories: Business Overview
6.10.2 Mayer Laboratories: Product Portfolio
6.11 Kessel Medintim GmbH
6.11.1 Kessel Medintim GmbH: Business Overview
6.11.2 Kessel Medintim GmbH: Product Portfolio
6.11.3 Kessel Medintim GmbH: Recent Developments (2014-2017)
6.12 Okamato Industries, Inc.
6.12.1 Okamato Industries, Inc.: Business Overview
6.12.2 Okamato Industries, Inc.: Product Portfolio
6.13 Agile Therapeutics, Inc.
6.13.1 Agile Therapeutics, Inc.: Business Overview
6.13.2 Agile Therapeutics, Inc.: Financial Overview
6.13.3 Agile Therapeutics, Inc.: Product Portfolio
6.14 Eurogine S.L.
6.14.1 Eurogine S.L.: Business Overview
6.14.2 Eurogine S.L.: Product Portfolio
7. Contraceptive Devices Market: Qualitative Analysis
7.1 SWOT Analysis
7.1.1 Global Contraceptive Devices Market Drivers
7.1.1.1 Availability of technologically advanced contraceptive devices
7.1.1.2 Rapidly growing population leading to high risk of sexually transmitted diseases (STDs) & HIV
7.1.1.3 Increasing awareness (campaigns/ programmes) and government initiatives related to contraceptive devices
7.1.2 Global Contraceptive Devices Market Weaknesses
7.1.2.1 Concerns associated with the use of contraceptive devices
7.1.2.2 High cost of contraceptives and increasing pricing pressure on manufacturers
7.1.2.3 Product recalls
7.1.3 Global Contraceptive Devices Market Opportunity
7.1.3.1 Focus on emerging markets
7.1.4 Global Contraceptive Devices Market Trend
7.1.4.1 Development of technologically advanced contraceptive devices
7.2 PEST Analysis
7.2.1 Political
7.2.2 Economic
7.2.3 Social
7.2.4 Technological
8. Conclusions and Recommendations
8.1 The Global Contraceptive Devices Market in 2016, 2017
and 2027
8.1.1 Current Leading Contraceptive Devices Segments
8.1.2 Leading Contraceptive Devices Companies
8.1.3 Leading Regional Markets
8.2 Global Contraceptive Devices Market Forecast 2016-2027
8.3 The Future of the Contraceptive Devices Market?
Appendices
Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Tables
Table 2.1 Contraceptive Devices, Pipeline Products, 2017
Table 3.1 Global Contraceptive Devices Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 3.2 Global Contraceptive Devices Market Forecast by Type: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 3.3 Contraceptive Devices Market Forecast by Geography: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 4.1 Global Condoms Market Forecast by Gender: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 4.2 Global Diaphragm Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 4.3 Global Sponges Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 4.4 Global Vaginal Rings Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 4.5 Global Subdermal/ Contraceptive Implant Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 4.6 Global Intrauterine Devices/ System’s Market Forecast by type: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.1 Contraceptive Devices Market Forecast Segmented by Regional Market: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 5.2 North American Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 5.3 U.S. Contraceptive Devices Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 5.4 Canada Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.5 Europe Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.6 U.K. Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.7 Germany Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.8 France Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.9 Italy Contraceptive Devices Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
Table 5.10 Rest of Europe Contraceptive Devices Market Forecast: Revenue ($m, AGR (%), CAGR (%), 2016-2027
Table 5.11 Asia-Pacific Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.12 China Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.13 Japan Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.14 India Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.15 Rest of Asia-Pacific Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.16 Rest of the World Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.17 Latin America Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 5.18 Middle East & Africa Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 6.1 Bayer - Company Overview
Table 6.2 Bayer AG – Product Portfolio
Table 6.3 Bayer AG – Recent Developments
Table 6.4 Reckitt Benckiser Group plc – Company Overview
Table 6.5 Reckitt Benckiser Group plc – Product Portfolio
Table 6.6 Reckitt Benckiser Group plc – Recent Developments
Table 6.7 Merck Sharp & Dohme Corp.– Company Overview
Table 6.8 Merck Sharp & Dohme Corp.– Product Portfolio
Table 6.9 Church & Dwight Co., Inc. – Company Overview
Table 6.10 Church & Dwight Co., Inc. – Product Portfolio
Table 6.11 Church & Dwight Co., Inc. – Recent Developments
Table 6.12 Teva Pharmaceuticals Industries Ltd. – Company Overview
Table 6.13 Teva Pharmaceuticals Industries Ltd. – Product Portfolio
Table 6.14 Teva Pharmaceuticals Industries Ltd. – Recent Developments
Table 6.15 Allergan Inc. – Company Overview
Table 6.16 Allergan Inc. – Product Portfolio
Table 6.17 Allergan Inc. – Recent Developments
Table 6.18 Ansell – Company Overview
Table 6.19 Ansell – Product Portfolio
Table 6.20 Ansell – Recent Developments
Table 6.21 The Female Health Company – Company Overview
Table 6.22 The Female Health Company – Product Portfolio
Table 6.23 The Female Health Company – Recent Developments
Table 6.24 Karex Industries – Recent Developments
Table 6.25 Karex Industries – Product Portfolio
Table 6.26 Karex Industries – Recent Developments
Table 6.27 Mayer Laboratories – Recent Developments
Table 6.28 Mayer Laboratories – Product Portfolio
Table 6.29 Kessel Medintim Gmbh – Company Overview
Table 6.30 Kessel Medintim Gmbh – Product Portfolio
Table 6.31 Kessel Medintim Gmbh – Recent Developments
Table 6.32 Okamato Industries, Inc.– Company Overview
Table 6.33 Okamato Industries, Inc.– Product Portfolio
Table 6.34 Agile Therapeutics, Inc. – Company Overview
Table 6.35 Agile Therapeutics, Inc. – Product Portfolio
Table 6.36 Eurogine, S.L. – Company Overview
Table 6.37 Eurogine, SL – Product Portfolio
Table 7.1 List of Product Recalls
Table 7.2 Contraceptive Devices Approved and Available in 2016
List of Figures
Figure 1.1 Global Contraceptive Devices Market Segmentation Overview, 2017
Figure 2.1 Snapshot: Evolution of Contraceptive Devices
Figure 3.1 Global Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)
Figure 3.2 Global Contraceptive Devices Market Forecast by Type: 2016-2027 ($m, AGR%)
Figure 3.3 Contraceptive Devices Market Forecast by Geography: 2016-2027 ($m, AGR%)
Figure 3.4 Contraceptive Devices Market Dynamics, 2017
Figure 4.1 Global Contraceptive Device Market by Type: Market Share (%), 2017
Figure 4.2 Global Contraceptive Device Market by Type: Market Share (%), 2022
Figure 4.3 Global Contraceptive Device Market by Type: Market Share (%), 2027
Figure 4.4 Global Condoms Market Forecast: 2016-2027 ($m, AGR%)
Figure 4.5 Global Condoms Contraceptive Device Market by Gender: Market Share (%), 2017
Figure 4.6 Global Condoms Contraceptive Device Market by Gender: Market Share (%), 2022
Figure 4.7 Global Condoms Contraceptive Device Market by Gender: Market Share (%), 2027
Figure 4.8Global Diaphragms Market Forecast: 2016-2027 ($m, AGR %)
Figure 4.9 Global Sponges Market Forecast: 2016-2027 ($m, AGR%)
Figure 4.10 Global Vaginal Rings Market: 2016-2027 ($m, AGR %)
Figure 4.11 Global Subdermal/ Contraceptive Implant Device Market: 2016-2027 ($m, AGR%)
Figure 4.12 Global Intrauterine Devices/ System’s Market Forecast by Type 2016-2027 ($m, AGR%)
Figure 4.13 Global Intrauterine Devices/System’s Market by Sub-Segment: Market Share (%), 2017
Figure 4.14 Global Intrauterine Devices/ System’s Market by Sub-Segment: Market Share (%), 2022
Figure 4.15 Global Intrauterine Devices/ System’s Market by Sub-Segment: Market Share (%), 2027
Figure 5.1 Contraceptive Devices Market Forecast Segmented by Regional Market: 2016-2027 ($m, AGR %)
Figure 5.2 Contraceptive Devices Market by Region: Market Share (%), 2017
Figure 5.3 Contraceptive Devices Market by Region: Market Share (%), 2022
Figure 5.4 Contraceptive Devices Market by Region: Market Share (%), 2027
Figure 5.5 North America Contraceptive Use by Type, 2015
Figure 5.6 Europe Contraceptive Use by Type, 2015
Figure 5.7 Asia Contraceptive Use by Type, 2015
Figure 5.8 Latin America & Caribbean Contraceptive Use by Type, 2015
Figure 5.9 Africa Contraceptive Use by Type, 2015
Figure 5.10 North American Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.11 North American Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027 ($m, AGR %)
Figure 5.12 North American Contraceptive Devices Market by Country: Market Share (%), 2017
Figure 5.13 North American Contraceptive Devices Market by Country: Market Share (%), 2022
Figure 5.14 North American Contraceptive Devices Market by Country: Market Share (%), 2027
Figure 5.15 U.S. Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.16 Canada Contraceptive Devices Market Forecast: 2017-2027 ($m, AGR %)
Figure 5.17 Europe Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)
Figure 5.18 Europe Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027 ($, AGR %)
Figure 5.19 Europe Contraceptive Devices Market by Country: Market Share (%), 2017
Figure 5.20 Europe Contraceptive Devices Market by Country: Market Share (%), 2022
Figure 5.21 Europe Contraceptive Devices Market by Country: Market Share (%), 2027
Figure 5.22 U.K. Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.23 Germany Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.24 France Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.25 Italy Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)
Figure 5.26 Rest of Europe Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)
Figure 5.27 Asia-Pacific Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.28 Asia-Pacific Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027 ($m, AGR %)
Figure 5.29 Asia-Pacific Contraceptive Devices Market by Country: Market Share (%), 2017
Figure 5.30 Asia-Pacific Contraceptive Devices Market by Country: Market Share (%), 2022
Figure 5.31 Asia-Pacific Contraceptive Devices Market by Country: Market Share (%), 2027
Figure 5.32 China Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.33 Japan Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)
Figure 5.34 India Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)
Figure 5.35 Rest of Asia-Pacific Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.36 Rest of the World Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)
Figure 5.37 Rest of the World Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.38 Rest of the World Contraceptive Devices Market by Country: Market Share (%), 2017
Figure 5.39 Rest of the World Contraceptive Devices Market by Country: Market Share (%), 2022
Figure 5.40 Rest of the World Contraceptive Devices Market by Country: Market Share (%), 2022
Figure 5.41 Latin America Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 5.42 Middle East & Africa Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)
Figure 6.1 Bayer AG – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments
Figure 6.2 Bayer AG – SWOT Analysis
Figure 6.3 Reckitt Benckiser – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments
Figure 6.4 Reckitt Benckiser Group plc – SWOT Analysis
Figure 6.5 Merck Sharp & Dohme Corp. (A Subsidiary of Merck & Co.) – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments
Figure 6.6 Merck Sharp & Dohme Corp. – SWOT Analysis
Figure 6.7 Church & Dwight., Inc. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments
Figure 6.8 Teva Pharmaceuticals Industries, Ltd. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments
Figure 6.9 Allergan Inc. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments
Figure 6.10 Allergan, PLC. – SWOT Analysis
Figure 6.11 Ansell Ltd. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments
Figure 6.12 Ansell Limited (Now Humanwell) – SWOT Analysis
Figure 6.13 The Female Health Company – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Geographical Segments 2016
Figure 6.14 Karex Industries – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments & Geographical Segments
Figure 6.15 Karex Industries – SWOT Analysis
Figure 6.16 Agile Therapeutics – Historical R&D Revenue
Figure 8.1 Global Contraceptive Devices Market, 2016
Figure 8.2 Global Contraceptive Devices Market, 2017
Figure 8.3 Global Contraceptive Devices Market, 2027
Figure 8.4 Global Leading Contraceptive Devices Segments, 2016
Figure 8.5 Leading Regional Markets, 2016
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
